Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection
Open Access
- 24 May 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 216 (1), 55-63
- https://doi.org/10.1093/infdis/jix247
Abstract
There is a substantial need for novel therapeutics to combat the widespread impact caused by Crytosporidium infection. However, there is a lack of knowledge as to which drug pharmacokinetic (PK) characteristics are key to generate an in vivo response, specifically whether systemic drug exposure is crucial for in vivo efficacy. To identify which PK properties are correlated with in vivo efficacy, we generated physiologically based PK models to simulate systemic and gastrointestinal drug concentrations for a series of bumped kinase inhibitors (BKIs) that have nearly identical in vitro potency against Cryptosporidium but display divergent PK properties. When BKI concentrations were used to predict in vivo efficacy with a neonatal model of Cryptosporidium infection, these concentrations in the large intestine were the sole predictors of the observed in vivo efficacy. The significance of large intestinal BKI exposure for predicting in vivo efficacy was further supported with an adult mouse model of Cryptosporidium infection. This study suggests that drug exposure in the large intestine is essential for generating a superior in vivo response, and that physiologically based PK models can assist in the prioritization of leading preclinical drug candidates for in vivo testing.Keywords
Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
This publication has 47 references indexed in Scilit:
- Health care seeking for Childhood Diarrhea in Developing Countries: Evidence from Seven Sites in Africa and AsiaThe American Journal of Tropical Medicine and Hygiene, 2013
- Mechanism-Based Pharmacodynamic ModelingPublished by Springer Science and Business Media LLC ,2012
- Expansion of Intestinal Epithelial Stem Cells during Murine DevelopmentPLOS ONE, 2011
- Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose OptimizationAntimicrobial Agents and Chemotherapy, 2011
- Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokineticsBulletin of the World Health Organization, 2011
- CRYPTOSPORIDIUM PARVUM ATTACHMENT TO AND INTERNALIZATION BY HUMAN BILIARY EPITHELIA IN VITRO: A MORPHOLOGIC STUDYJournal of Parasitology, 2004
- Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetic and Pharmacodynamic Parameters for Antimicrobial Effects of Cefotaxime and Amoxicillin in an In Vitro Kinetic ModelAntimicrobial Agents and Chemotherapy, 2001
- Malnutrition and Pharmacokinetics of Penicillin in Ethiopian ChildrenBasic & Clinical Pharmacology & Toxicology, 1995
- Chronic Cryptosporidium parvum Infections in Congenitally Immunodeficient SCID and Nude MiceThe Journal of Infectious Diseases, 1991